Absorption-enhanced berberine (dihydroberberine, or micellar, emulsified or phospholipid berberine) raises blood berberine more than standard berberine hydrochloride at the same or a higher dose.
4 sources: 4 positive.
Researchers say
No researcher counted yet.
Studies show
4 positive
4 papers we read
-
Other primary study, Evid Based Complement Alternat Med, 2021, PMID 34904017
Positive Study
Read the paper on PubMed →The AUClast value of BBR-PP tablet is about 4 times (for total berberine) and 2.4 times (for free berberine) higher than values from berberine chloride.
-
Controlled trial, Nutrients, 2021, PMID 35010998
Positive Study
Read the paper on PubMed →Significantly higher berberine AUC values were identified for D100 (284.2 ± 115.9 ng/mL Berberine/120 min) when compared to placebo (20.2 ± 16.2 ng/mL Berberine/120 min, p = 0.007) and B500 (42.3 ± 17.5 ng/mL Berberine/120 min, p = 0.007).
-
Other primary study, Pharmaceutics, 2023, PMID 38004546
Positive Study
Read the paper on PubMed →LMB achieved significantly higher absorption when compared to unformulated/standard berberine (AUC: 78.2 ± 14.4 ng h/mL vs. 13.4 ± 1.97 ng h/mL; p < 0.05, respectively).
-
Other primary study, ACS Omega, 2025, PMID 40949215
Positive Study
Read the paper on PubMed →BerbiQ demonstrated a significantly (P < 0.001) higher bioavailability than conventional berberine, with a 4.26-fold increase based on AUC0–48.
1 more not counted · see why
The study is not yet read in full. 1
Show the receipts from 4 sources
-
Other primary study, Evid Based Complement Alternat Med, 2021, PMID 34904017 Study · positive
The AUClast value of BBR-PP tablet is about 4 times (for total berberine) and 2.4 times (for free berberine) higher than values from berberine chloride.
-
Controlled trial, Nutrients, 2021, PMID 35010998 Study · positive
Significantly higher berberine AUC values were identified for D100 (284.2 ± 115.9 ng/mL Berberine/120 min) when compared to placebo (20.2 ± 16.2 ng/mL Berberine/120 min, p = 0.007) and B500 (42.3 ± 17.5 ng/mL Berberine/120 min, p = 0.007).
-
Other primary study, Pharmaceutics, 2023, PMID 38004546 Study · positive
LMB achieved significantly higher absorption when compared to unformulated/standard berberine (AUC: 78.2 ± 14.4 ng h/mL vs. 13.4 ± 1.97 ng h/mL; p < 0.05, respectively).
-
Other primary study, ACS Omega, 2025, PMID 40949215 Study · positive
BerbiQ demonstrated a significantly (P < 0.001) higher bioavailability than conventional berberine, with a 4.26-fold increase based on AUC0–48.